Udg Healthcare PLC (LON:UDG)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $718.59 and traded as low as $711.00. Udg Healthcare shares last traded at $725.50, with a volume of 275,646 shares traded.
UDG has been the topic of a number of recent analyst reports. Liberum Capital reissued a “buy” rating on shares of Udg Healthcare in a research report on Wednesday, August 7th. Royal Bank of Canada lowered shares of Udg Healthcare to a “sector performer” rating and reduced their price objective for the stock from GBX 830 ($10.85) to GBX 800 ($10.45) in a research report on Monday, August 12th. Berenberg Bank increased their price objective on shares of Udg Healthcare from GBX 700 ($9.15) to GBX 850 ($11.11) and gave the stock a “hold” rating in a research report on Tuesday, August 20th. Finally, Peel Hunt reaffirmed a “buy” rating on shares of Udg Healthcare in a research report on Monday, September 2nd. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of GBX 814.14 ($10.64).
The firm has a market capitalization of $1.84 billion and a PE ratio of 71.84. The stock’s 50-day moving average price is GBX 764.80 and its 200 day moving average price is GBX 719.87. The company has a debt-to-equity ratio of 26.96, a current ratio of 1.94 and a quick ratio of 1.85.
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.
Featured Article: Gross Domestic Product (GDP)
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.